Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Corcept Therapeutics (CORT) Non Operating Income (2018 - 2025)

Historic Non Operating Income for Corcept Therapeutics (CORT) over the last 8 years, with Q3 2025 value amounting to $5.0 million.

  • Corcept Therapeutics' Non Operating Income fell 2081.95% to $5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.9 million, marking a year-over-year decrease of 17.84%. This contributed to the annual value of $24.5 million for FY2024, which is 4206.66% up from last year.
  • As of Q3 2025, Corcept Therapeutics' Non Operating Income stood at $5.0 million, which was down 2081.95% from $5.0 million recorded in Q2 2025.
  • In the past 5 years, Corcept Therapeutics' Non Operating Income ranged from a high of $6.7 million in Q4 2024 and a low of $72000.0 during Q3 2021
  • Its 5-year average for Non Operating Income is $3.3 million, with a median of $3.6 million in 2023.
  • Per our database at Business Quant, Corcept Therapeutics' Non Operating Income plummeted by 8910.89% in 2021 and then soared by 437625.0% in 2023.
  • Over the past 5 years, Corcept Therapeutics' Non Operating Income (Quarter) stood at $72000.0 in 2021, then surged by 2368.06% to $1.8 million in 2022, then skyrocketed by 189.25% to $5.1 million in 2023, then skyrocketed by 30.31% to $6.7 million in 2024, then decreased by 24.99% to $5.0 million in 2025.
  • Its last three reported values are $5.0 million in Q3 2025, $5.0 million for Q2 2025, and $6.2 million during Q1 2025.